Pre-treatment: Measure morning resting heart rate for 7 days Consider baseline ECG if not done recently Review all medications for cardiac interactions Discuss with physician specifically about the glucagon receptor heart rate effect During treatment: Measure resting heart rate daily during dose escalation Continue at each dose for minimum 6 to 8 weeks before increasing If resting HR exceeds baseline by more than 10 BPM, hold dose If resting HR exceeds 90 BPM at rest consistently, consult physician before any further increases Consider microdosing approach for ultra-gradual escalation Expected timeline: Weeks 1-12: very gradual heart rate change at low doses Weeks 12-30: moderate increase as dose slowly climbs Weeks 30+: stabilization (may occur later than standard protocol due to slower escalation) Protocol 3: monitoring-enhanced approach for data-driven researchers Who this is for: Researchers who want comprehensive data, athletes tracking performance metrics, anyone who finds data reassuring
Patients should discuss long-term medication plans before surgery to ensure alignment between weight management and aesthetic goals
The resulting active compounds cause damage to the cells in the lining of the intestine and leads to apoptosis (a form of cell death)
We confirm that co-treatment with 5FU and mitochondrial inhibitors, particularly CI inhibitors IACS-010759 (a specific CI inhibitor under clinical evaluation 51 ) and metformin hydrochloride (a treatment for diabetes that inhibits CI 52 ), increases growth arrest and death in CRC cells (Fig
Ethical Approval This study was conducted according to the guidelines of the Declaration of Helsinki of 1964 and its later amendments and the STROBE guidelines
Adequate selenium intake further supports enzymatic processes involved in glutathione synthesis
